Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family

Clinical Immunology

Volumn 100, Issue 1, 2001, Pages 15-23

  Lewis, Jennifer ^a   Eiben, Lisa J ^a   Nelson, David L ^a   Cohen, Jeffrey I ^b   Nichols, Kim E ^c   Ochs, Hans D ^d   Notarangelo, Luigi D ^e   Duckett, Colin S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

CD84; Duncan's disease; SAP; SLAM; X linked lymphoproliferative syndrome

Indexed keywords

CD150 ANTIGEN; CD2 ANTIGEN; CELL SURFACE RECEPTOR; GENE PRODUCT; LYMPHOCYTE ANTIGEN RECEPTOR; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; DUNCAN DISEASE; EPSTEIN BARR VIRUS; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; MISSENSE MUTATION; NONSENSE MUTATION; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; X CHROMOSOME LINKED DISORDER;

EID: 0034952689     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5035     Document Type: Article

References (38)

1. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)
2. The X-linked lymphoproliferative disease: From autopsy toward cloning the gene 1975-1990
3. X-linked lymphoproliferative disease: Twenty-five years after the discovery
4. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects
5. Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects
6. Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome
7. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
8. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
9. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
10. SLAM (CDw150) is a cellular receptor for measles virus
11. A novel receptor involved in T-cell activation
12. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP
13. CD84 leukocyte antigen is a new member of the Ig superfamily
14. CD84
15. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity
16. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome
17. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
18. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases
19. L and cytochrome c
20. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2
21. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition
22. Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease
23. A novel phosphotyrosine motif with a critical amino acid at position - 2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1
24. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling
25. Involvement of SHP-2 in multiple aspects of IL-2 signaling: Evidence for a positive regulatory role
26. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis
27. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
28. Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase
29. The structure and ligand interactions of CD2: Implications for T-cell function
30. 2B4: An NK cell activating receptor with unique specificity and signal transduction mechanism
31. Physical and genetic linkage of the genes encoding Ly-9 and CD48 on mouse and human chromosomes 1
32. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A
33. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients
34. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease
35. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kB
36. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus
37. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production
38. The CD2-subset of the Ig superfamily of cell surface molecules: Receptor-ligand pairs expressed by NK cells and other immune cells